Charles Schwab Investment Management Inc. Purchases 34,491 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Charles Schwab Investment Management Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 0.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,816,080 shares of the healthcare conglomerate’s stock after acquiring an additional 34,491 shares during the quarter. UnitedHealth Group accounts for about 0.8% of Charles Schwab Investment Management Inc.’s investment portfolio, making the stock its 24th largest holding. Charles Schwab Investment Management Inc. owned about 0.63% of UnitedHealth Group worth $2,783,890,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. 25 LLC bought a new stake in UnitedHealth Group in the 1st quarter valued at $28,000. Cascade Investment Advisors Inc. bought a new position in shares of UnitedHealth Group during the first quarter worth about $28,000. Kalos Management Inc. bought a new stake in UnitedHealth Group in the 1st quarter valued at approximately $34,000. Strategic Investment Solutions Inc. IL bought a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $35,000. Finally, Clear Investment Research LLC lifted its position in shares of UnitedHealth Group by 216.7% in the first quarter. Clear Investment Research LLC now owns 76 shares of the healthcare conglomerate’s stock worth $36,000 after purchasing an additional 52 shares in the last quarter. Institutional investors own 85.69% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 4,498 shares of the company’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the sale, the executive vice president now directly owns 9,218 shares in the company, valued at $5,017,173.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 4,498 shares of the business’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the transaction, the executive vice president now owns 9,218 shares of the company’s stock, valued at $5,017,173.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 121,515 shares of the company’s stock in a transaction that occurred on Tuesday, October 17th. The stock was sold at an average price of $540.58, for a total transaction of $65,688,578.70. Following the transaction, the director now owns 521,818 shares of the company’s stock, valued at $282,084,374.44. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on UNH shares. Stephens reissued an “overweight” rating and set a $560.00 price target on shares of UnitedHealth Group in a research report on Friday, August 11th. Sanford C. Bernstein upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and raised their price target for the company from $595.00 to $603.00 in a research note on Tuesday, July 18th. Jefferies Financial Group increased their price objective on UnitedHealth Group from $529.00 to $531.00 and gave the company a “hold” rating in a report on Monday, October 9th. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a research report on Monday, October 23rd. Finally, Royal Bank of Canada boosted their price objective on shares of UnitedHealth Group from $572.00 to $596.00 and gave the stock an “outperform” rating in a research note on Monday, October 16th. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $578.30.

View Our Latest Research Report on UNH

UnitedHealth Group Trading Down 0.4 %

Shares of UnitedHealth Group stock opened at $540.38 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $553.00. The stock has a market cap of $499.81 billion, a PE ratio of 23.45, a PEG ratio of 1.65 and a beta of 0.63. The firm has a 50-day moving average of $516.06 and a 200-day moving average of $497.54. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.80 and a current ratio of 0.80.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Friday, October 13th. The healthcare conglomerate reported $6.56 EPS for the quarter, topping the consensus estimate of $6.33 by $0.23. The company had revenue of $92.36 billion for the quarter, compared to analysts’ expectations of $91.41 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.58%. The business’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period last year, the firm earned $5.79 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 24.94 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, December 4th will be given a dividend of $1.88 per share. The ex-dividend date of this dividend is Friday, December 1st. This represents a $7.52 annualized dividend and a yield of 1.39%. UnitedHealth Group’s dividend payout ratio is 32.64%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.